1. Market Research
  2. > Healthcare
  3. > Pathology Market Trends
  4. > Ankylosing Spondylitis (Bekhterev%s Disease)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017


DelveInsight’s Report, “Ankylosing Spondylitis (Bekhterev's Disease)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturersacross the globe. A key objective of the Ankylosing Spondylitis (Bekhterev's Disease) Report is to understand the market and pipeline status of the drugs around the Ankylosing Spondylitis (Bekhterev's Disease) to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on designing pipeline startegies. The DelveInsight’s Report provides the historical and forecasted sales of the drugs till 2018. The Report gives insights into patents providing the patent protection data and marketing exclusivity of all the drugs across the Ankylosing Spondylitis (Bekhterev's Disease). While the leading brands, companies and chemicals are considered thoroughly, DelveInsight’s report also provides details on the Global API Manufacturers across the globe covering Drug Master Filings of US, Europe and API Manufacturers in Asia specifically China and India.

Please note:This report requires certain updates. We have all the information available but require 48-72 Hours to complete the process and ensure it is as up-to-date as possible. Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

SCOPE:
- A snapshot of the global Market and Phase III therapeutics scenario for Ankylosing Spondylitis (Bekhterev's Disease).
- A review of the marketed products under prescription for Ankylosing Spondylitis (Bekhterev's Disease), regulatory information and marketing status.
- Coverage of global patent coverage and detailed commentaries on the US patent challenges.
- Graphical representation of investigational products for patent expiry and market exclusivities across the globe.
- Product profiles for marketed products for Ankylosing Spondylitis (Bekhterev's Disease) with complete description of mechanism of action, therapeutic class, target, route(s) of administration and chemical details.
- Coverage of API Manufacturers for Ankylosing Spondylitis (Bekhterev's Disease) drugs in the United States, Europe and Asian Regions with location details.
- Coverage of Regulatory filings in theUS, Europe, and Asia specifically India and China for Ankylosing Spondylitis (Bekhterev's Disease) drugs.
- Coverage of Route of Synthesis of Active Pharmaceutical Ingredient associated with Ankylosing Spondylitis (Bekhterev's Disease) drugs.
- Coverage of Ankylosing Spondylitis (Bekhterev's Disease) Phase III pipeline products featuring sections on product description, mechanism of action, Chemical details and research & development progress.
- Coverage of the United States Drug Master File (US DMF) available for Phase III Pipeline Drugs.
- Key discontinued Marketed products.
- Global Sales Figure to 2018.

Reasons to buy:
- Evaluate the marketing status and exclusivity details of Ankylosing Spondylitis (Bekhterev's Disease) key products to exploit opportunities for generic drug development opportunities.
- Identify and understand important and diverse types of therapeutics under Phase III development for Ankylosing Spondylitis (Bekhterev's Disease).
- Design effective counter-strategies to gain competitive advantage by identifying the key patent expiry details and exclusivity with respect to Ankylosing Spondylitis (Bekhterev's Disease).
- API intelligence over marketed drugs forAnkylosing Spondylitis (Bekhterev's Disease)and gaining primary intelligence over active ingredients manufacturers across the globe.
- API intelligence over leading Phase III Pipeline drugs.
- Develop and designstrategies by identifying the API manufacturers for Phase III Pipeline products to enhance and expand business potential and scope.
- Understanding the scope of the Phase III Drugs with nil regulatory filings.
- Understanding the chemical route of synthesis of approved drugs for Ankylosing Spondylitis (Bekhterev's Disease).
- Uncovering opportunities in the rapidly growing US market.

Table Of Contents

Ankylosing Spondylitis (Bekhterev%s Disease)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017
Illustrative
1. Indication Overview
2. Market Drugs Landscape
2.1 Marketed Drugs
2.2 Marketed Details of Drugs by Application Type
2.3 Marketed Details of Drugs (NDA) by Marketing Status
2.4 Marketed Details of Drugs by Patent Expiration Timeline
3. Global API Manufacturers Assessment
3.1 API Manufacturers by United States Drug Master File (US DMF) Status
3.2 API Manufacturers by US DMF Status (Drug Specific)
3.3 API Manufacturers in Europe by Country
3.4 API Manufacturers in India by State
3.5 API Manufacturers in China by Province
3.6 Marketed Details of Approved Drugs by Geography
4. Phase III Drugs Landscape
4.1 Active Pharmaceutical Ingredient (API) Manufacturers Assessment for Phase III Pipeline Drugs
4.2 API Manufacturers by US DMF Status (Drug Specific)
5. Drugs Market Data and Forecasted Sales Figure-2018
6. Marketed Drugs for Ankylosing Spondylitis (Bekhterev's Disease)
6.1 Drug Name
6.1.1 Drug Description
6.1.2 Global Active Pharmaceutical Manufacturers for Drug
6.1.3 Approval Status of Drug
6.1.4 Patent and Exclusivity Details for Drug
6.1.5 Company Profile and Financials
7. Phase III Drugs for Ankylosing Spondylitis (Bekhterev's Disease)
7.1 Drug Name
7.1.1 Drug Description
7.1.2 United States Drug Master File (DMF)
8. Discontinued Drugs for Ankylosing Spondylitis (Bekhterev's Disease)
9. Appendix
10. Methodology
11. Consulting Services
12. Contact Us
13. Disclaimer


List of Tables

- Ankylosing Spondylitis (Bekhterev's Disease) Therapeutic Market, US, Marketed Drugs by Application Type, 2017
- Ankylosing Spondylitis (Bekhterev's Disease) Therapeutic Market, US, Marketed Drugs by Marketing Status, 2017
- Ankylosing Spondylitis (Bekhterev's Disease) Therapeutic Market, US, (Year), 2017
- Ankylosing Spondylitis (Bekhterev's Disease) Marketed Drugs, API Manufacturers by US DMF Status, 2017
- Ankylosing Spondylitis (Bekhterev's Disease) Marketed Drugs, US DMF Status Drug Specific (Number), 2017
- Ankylosing Spondylitis (Bekhterev's Disease) Drugs, API Manufacturers, Europe by Country, 2017
- Ankylosing Spondylitis (Bekhterev's Disease) Drugs, API Manufacturers, India by State, 2017
- Ankylosing Spondylitis (Bekhterev's Disease) Drugs, API Manufacturers, China by Province, 2017
- Ankylosing Spondylitis (Bekhterev's Disease) Drugs, API Manufacturers by Geography 2017
- Ankylosing Spondylitis (Bekhterev's Disease) Phase III Pipeline Drugs, US DMF Status Drug Specific (Number), 2017
- Ankylosing Spondylitis (Bekhterev's Disease) Therapeutic Market, Global Sales-2018 (in million USD)
- API Manufacturers for Drug, 2017
- Phase III Drugs for Ankylosing Spondylitis (Bekhterev's Disease), 2017
- Discontinued Drugs for Ankylosing Spondylitis (Bekhterev's Disease), 2017


List of Figures

- Ankylosing Spondylitis (Bekhterev's Disease) Therapeutic Market, US, Marketed Drugs by Application Type (%), 2017
- Ankylosing Spondylitis (Bekhterev's Disease) Therapeutic Market, US, Marketed Drugs by Marketing Status (%), 2017
- Ankylosing Spondylitis (Bekhterev's Disease) Therapeutic Market, US, (Year), 2017
- Ankylosing Spondylitis (Bekhterev's Disease) Marketed Drugs, API Manufacturers by US DMF Status (%), 2017
- Ankylosing Spondylitis (Bekhterev's Disease) Marketed Drugs, US DMF Status Drug Specific (Number), 2017
- Ankylosing Spondylitis (Bekhterev's Disease) Drugs, API Manufacturers, Europe by Country, 2017
- Ankylosing Spondylitis (Bekhterev's Disease) Drugs, API Manufacturers, India by State, 2017
- Ankylosing Spondylitis (Bekhterev's Disease) Drugs, API Manufacturers, China by Province, 2017
- Ankylosing Spondylitis (Bekhterev's Disease) Drugs, API Manufacturers by Geography 2017
- Ankylosing Spondylitis (Bekhterev's Disease) Phase III Pipeline Drugs, US DMF Status Drug Specific (Number), 2017
- Ankylosing Spondylitis (Bekhterev's Disease) Therapeutic Market, Global Sales 2018 (in million USD)
- Drug, Patent/Exclusivity Expiry (Year), 2017

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Psoriatic Arthritis - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Psoriatic Arthritis - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • December 2016
  • by GlobalData

PharmaPoint: Psoriatic Arthritis - Global Drug Forecast and Market Analysis to 2025 Summary Psoriatic arthritis (PsA) is a chronic immune-mediated arthritis typically affecting the large joints, especially ...

Human Microbiome Market by Indication, Application, Product, Product Research, Technology Research - Global Forecast to 2025

Human Microbiome Market by Indication, Application, Product, Product Research, Technology Research - Global Forecast to 2025

  • $ 5650
  • Industry report
  • March 2017
  • by MarketsandMarkets

The global human microbiome market is estimated to reach USD 899.1 million by 2025, growing at a CAGR of 21.1% during the forecast period (2022–2025) Factors such as increased focus on human microbiome ...

Ankylosing spondylitis (AS)- Market Insights, Epidemiology and Market Forecast-2023

Ankylosing spondylitis (AS)- Market Insights, Epidemiology and Market Forecast-2023

  • $ 4950
  • Industry report
  • January 2017
  • by Delve Insight

Note*: This report requires 5 business days to complete. DelveInsight’s Ankylosing spondylitis (AS) - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease ...


Download Unlimited Documents from Trusted Public Sources

Lymphoma Statistics in Germany

  • March 2017
    167 pages
  • Lymphoma  

    Cancer  

    Leukemia  

  • Germany  

    Europe  

    United States  

View report >

Diabetes Statistics in China

  • March 2017
    13 pages
  • Diabetes  

  • China  

View report >

Cardiovascular Disease Statistics in the US

  • March 2017
    8 pages
  • Cardiovascular ...  

  • United States  

View report >

Related Market Segments :

Autoimmune Disease

ref:plp2017

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.